1
/
의
1
ELK Biotechnology
SKU(재고 관리 코드):ES14253
PASD1 rabbit pAb
PASD1 rabbit pAb
Applications: WB
Reactivity: Human;Rat;Mouse;
Source: Rabbit
Dilution: WB 1:500-2000
Immunogen: Synthesized peptide derived from human PASD1 AA range: 710-760
Storage_stability: -20°C/1 year
Clonality: Polyclonal
Isotype: IgG
Concentration: 1 mg/ml
Observed_band(KD): 85kD
Human_gene_id: 139135
Human_swiss_prot_no: Q8IV76
Subcellular_location: [Isoform 1]: Nucleus . Associates preferentially at the periphery of the nucleus with heterochromatin (PubMed:25936801). .; [Isoform 2]: Nucleus . Associates preferentially at the periphery of the nucleus with heterochromatin (PubMed:25936801). .
Other_name: PAS domain-containing protein 1 (Cancer/testis antigen 63) (CT63) (OX-TES-1)
Background: This gene encodes a protein that is thought to function as a transcription factor. The protein is a cancer-associated antigen that can stimulate autologous T-cell responses, and it is therefore considered to be a potential immunotherapeutic target for the treatment of various hematopoietic malignancies, including diffuse large B-cell lymphoma. [provided by RefSeq, May 2010],
Reactivity: Human;Rat;Mouse;
Source: Rabbit
Dilution: WB 1:500-2000
Immunogen: Synthesized peptide derived from human PASD1 AA range: 710-760
Storage_stability: -20°C/1 year
Clonality: Polyclonal
Isotype: IgG
Concentration: 1 mg/ml
Observed_band(KD): 85kD
Human_gene_id: 139135
Human_swiss_prot_no: Q8IV76
Subcellular_location: [Isoform 1]: Nucleus . Associates preferentially at the periphery of the nucleus with heterochromatin (PubMed:25936801). .; [Isoform 2]: Nucleus . Associates preferentially at the periphery of the nucleus with heterochromatin (PubMed:25936801). .
Other_name: PAS domain-containing protein 1 (Cancer/testis antigen 63) (CT63) (OX-TES-1)
Background: This gene encodes a protein that is thought to function as a transcription factor. The protein is a cancer-associated antigen that can stimulate autologous T-cell responses, and it is therefore considered to be a potential immunotherapeutic target for the treatment of various hematopoietic malignancies, including diffuse large B-cell lymphoma. [provided by RefSeq, May 2010],
Share
